Future meeting - Haifa, October, 2012 The EORTC was created in 1962 by Henri Tagnon and a few pioneers who foresaw the need for establishing a European research structure to develop cooperative clinical research. It was named GECA: Groupe Europeen de Chimiotherapie Anti-cancereuse which in 1968 became the EORTC (European Organisation for Research and Treatment of Cancer). The Radiotherapy Group was and has remained one of the most active in developing joint research ventures with other EORTC groups; in particular with the Urology, Gastro-Intestinal, Brain Tumor and Breast Groups, leading to pivotal trials that contributed to change practice. Several "mega-trials" (above 1000 patients) were implemented in the nineties. Some documents are available in Portable Document Format (PDF) for both viewing and printing. PDF preserves the original format of the documents, and all you need to view them is Adobe Acrobat Reader, which you can download here For comments and suggestions about the web site, send mail to webmaster  Varian supports QA RT in the joint RTOG/EORTC study on pancreatic cancer (40084-22084) : The ROG gratefully acknowledges the support of Varian for QA in this study. As many centres will be credentialled for the use of IMRT, this support will be used to cover the cost of transportation of the phantom and evaluation of measurements for the 40 EORTC centres participating in this study. 
Last update: 14 May 2012 ©EORTC ROG 2002-2011
|
